Cargando…

Prognostic and Immunological Role of STK38 across Cancers: Friend or Foe?

Although STK38 (serine-threonine kinase 38) has been proven to play an important role in cancer initiation and progression based on a series of cell and animal experiments, no systemic assessment of STK38 across human cancers is available. We firstly performed a pan-cancer analysis of STK38 in this...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Yankuo, Shi, Zhiyuan, Zheng, Zeyuan, Li, Jinxin, Yang, Kunao, Xu, Chunlan, Liu, Qing, Gong, Zhicheng, Yang, Yi, Zhao, Yue, Xuan, Zuodong, Sun, Huimin, Shao, Chen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9570386/ https://www.ncbi.nlm.nih.gov/pubmed/36232893 http://dx.doi.org/10.3390/ijms231911590

Ejemplares similares

The Crucial Role of AR-V7 in Enzalutamide-Resistance of Castration-Resistant Prostate Cancer
por: Zheng, Zeyuan, et al.
Publicado: (2022)

BCKDK regulates breast cancer cell adhesion and tumor metastasis by inhibiting TRIM21 ubiquitinate talin1
por: Xu, Chunlan, et al.
Publicado: (2023)

Branched‐chain keto‐acid dehydrogenase kinase regulates vascular permeability and angiogenesis to facilitate tumor metastasis in renal cell carcinoma
por: Yang, Kunao, et al.
Publicado: (2023)

TOPK mediates immune evasion of renal cell carcinoma via upregulating the expression of PD-L1
por: Li, Jinxin, et al.
Publicado: (2023)

Establishment and validation of a novel anoikis-related prognostic signature of clear cell renal cell carcinoma
por: Liu, Yankuo, et al.
Publicado: (2023)

P38 MAPK and Radiotherapy: Foes or Friends?
por: García-Flores, Natalia, et al.
Publicado: (2023)

The prognostic and immunological effects of ZBTB7C across cancers: friend or foe?
por: Chen, Xuenuo, et al.
Publicado: (2021)

The Aryl Hydrocarbon Receptor in Chronic Kidney Disease: Friend or Foe?
por: Mo, Yenan, et al.
Publicado: (2020)

Targeting the hedgehog pathway in MET mutation cancers and its effects on cells associated with cancer development
por: Du, Yifan, et al.
Publicado: (2023)

ZEB Proteins in Leukemia: Friends, Foes, or Friendly Foes?
por: Soen, Bieke, et al.
Publicado: (2018)

Friend and Foe
Publicado: (1890)

Nuclear Antigens and Auto/Alloantibody Responses: Friend or Foe in Transplant Immunology
por: Nakano, Toshiaki, et al.
Publicado: (2013)

Review of ferroptosis in colorectal cancer: Friends or foes?
por: Wu, Zheng, et al.
Publicado: (2023)

Exosomes in metastasis of colorectal cancers: Friends or foes?
por: Wu, Zheng, et al.
Publicado: (2023)

Calcification in Atherosclerotic Plaque Vulnerability: Friend or Foe?
por: Shi, Xuan, et al.
Publicado: (2020)

Fibronectin in Cancer: Friend or Foe
por: Lin, Tsung-Cheng, et al.
Publicado: (2019)

A Friend or Foe: Calcineurin across the Gamut of Neurological Disorders
por: Saraf, Jackson, et al.
Publicado: (2018)

Phytoestrogens. Friends or foes?
por: Barrett, J
Publicado: (1996)

Polypill—Friend or Foe?
por: Rishi, Rakesh Kumar
Publicado: (2011)

Antioxidants - friend or foe?
por: Meffert, Hans
Publicado: (2008)

Inflammation: Friend and Foe
por: Kjekshus, John
Publicado: (2015)

Leukocytes: friend or foe
por: Bellingan, G
Publicado: (2000)

Viruses: Friends or foes
por: Michán, Carmen, et al.
Publicado: (2021)

Sphingolipids: Friends or Foes?
por: Hayashi, Hiroshi
Publicado: (2022)

Gabapentin—Friend or foe?
por: Russo, Marc, et al.
Publicado: (2022)

The Aryl Hydrocarbon Receptor Meets Immunology: Friend or Foe? A Little of Both
por: Julliard, Walker, et al.
Publicado: (2014)

STK38 is a PPARγ-interacting protein promoting adipogenesis
por: Qian, Kun, et al.
Publicado: (2021)

Antibiotics and immunotherapy in gastrointestinal tumors: Friend or foe?
por: Yan, Cong, et al.
Publicado: (2019)

Adiponectin: friend or foe in obesity and inflammation
por: Luo, Liping, et al.
Publicado: (2022)

Lithium in Cancer Therapy: Friend or Foe?
por: Yang, Chunhao, et al.
Publicado: (2023)

Friends or foes: The mononuclear phagocyte system in ischemic stroke
por: Ziqing, Zhang, et al.
Publicado: (2023)

Adipose tissue and hematopoiesis: Friend or foe?
por: He, Na, et al.
Publicado: (2023)

Interleukin-33 in Malignancies: Friends or Foes?
por: Shen, Jia-Xin, et al.
Publicado: (2018)

Neutrophils in traumatic brain injury (TBI): friend or foe?
por: Liu, Yang-Wuyue, et al.
Publicado: (2018)

Natural killer cells in sepsis: Friends or foes?
por: Wang, Fangjie, et al.
Publicado: (2023)

Media and breastfeeding: Friend or foe?
por: Brown, Jane D, et al.
Publicado: (2008)

Friend to the brain, foe to the spine
por: Maxmen, Amy
Publicado: (2008)

Podiatric surgery: friend or foe?
por: Prior, Trevor D
Publicado: (2011)

Medicine And Money: Friends Or Foe?
por: Muula, Adamson S.
Publicado: (2006)

Bacterial toxins: friends or foes?
por: Schmitt, C K, et al.
Publicado: (1999)

Cannot write session to /tmp/vufind_sessions/sess_67f96hnq5h7acrdlnd8rl1gdrk